Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer.

Medicine - 9 Oct 2020

Sheng Mingyan, Tong Haofei, Lu Xiaoyan, Shanshan Ni, Zhang Xingguo, Reddy B Ashok, Shu Peng

Abstract excerpt

BACKGROUND: Epithelial ovarian cancer (EOC) has been classified into four molecular subtypes, of which the mesenchymal subtype has the poorest survival. Our goal is to develop an immune-based prognostic signature by incorporating molecular subtypes for EOC patients. METHODS: The gene expression profiles of EOC samples were collected from seven public datasets as well as an internal retrospective validation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ovarian Epithelial

Share to Epithelial-Mesenchymal Transition

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 33031300
DOI: 10.1097/MD.0000000000022549
PMCID: PMC10545305

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer.PMID 33031300Read ↗

Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian CancerSemantic proximity Read ↗

Development and validation of an immune gene-set based Prognostic signature in ovarian cancerSemantic proximity Read ↗

Development of a Multi-gene-based Immune Prognostic Signature in Ovarian CancerSemantic proximity Read ↗

Multiomics and Machine Learning Identify Prognostic Immune Related Gene Signatures in Ovarian CancerSemantic proximity Read ↗

A Risk Model Based on Tumor Microenvironment to Predict Survival and Immunotherapy Efficacy for Ovarian CancerSemantic proximity Read ↗

Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancerSemantic proximity Read ↗

A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancerSemantic proximity Read ↗

Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patientsSemantic proximity Read ↗

Prognostic risk model of immune-related genes in ovarian cancerSemantic proximity Read ↗

Identification of the immune subtype of ovarian cancer patients by integrated analyses of transcriptome and single-cell sequencing dataSemantic proximity Read ↗

Integrated Bioinformatical Analysis for Identification the invasion-related Genes in ovarian cancerSemantic proximity Read ↗

Prognostic Risk Model of Immune-Related Genes In Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.